(Updated - May 9, 2023 5:06 PM EDT)

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q1 EPS of ($0.50), $0.07 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

Earnings